Understanding Menopause: Symptoms, Treatment Options, and Long-Term Health

Menopause marks the permanent cessation of menstruation (12 consecutive months without a period), typically occurring at median age 51–52. It results from ovarian follicular depletion and declining estradiol/progesterone. Perimenopause (the transition) begins years earlier with irregular cycles and symptom onset.

Common Symptoms

• Vasomotor: Hot flashes (75–80%), night sweats — often most disruptive
• Genitourinary (GSM): Vaginal dryness, dyspareunia, urinary urgency, recurrent UTIs
• Sleep disturbance: Insomnia, night sweats, sleep architecture changes
• Mood: Irritability, anxiety, depressive symptoms (↑ risk with history)
• Cognitive: "Brain fog," word-finding difficulty, concentration issues
• Physical: Joint/muscle pain, weight redistribution (central adiposity), skin/hair changes
• Sexual: Decreased libido, arousal difficulty

Treatment Options

Menopausal Hormone Therapy (MHT/HT)

• Gold standard for vasomotor symptoms and GSM
• Estrogen + progestogen (if uterus intact); estrogen alone (hysterectomy)
• Routes: Transdermal (patch/gel/spray) preferred — lower VTE risk vs. oral
• Timing: "Window of opportunity" <60 or <10 yrs post-menopause for CV benefit
• Contraindications: Breast/endometrial cancer, VTE/stroke history, active liver disease, unexplained bleeding

Non-Hormonal Prescription Options

• SSRIs/SNRIs (paroxetine, venlafaxine, escitalopram): Vasomotor + mood
• Gabapentin/pregabalin: Night sweats, sleep
• Fezolinetant (NK3R antagonist): New non-hormonal for moderate-severe hot flashes
• Oxybutynin: Off-label for hot flashes

Non-Pharmacologic / Complementary

• CBT-I: For insomnia
• Clinical hypnosis, mindfulness: Evidence for hot flash reduction
• Vaginal moisturizers/lubricants: First-line for GSM
• Low-dose vaginal estrogen: Safe for most; minimal systemic absorption
• Exercise: Aerobic + resistance; improves vasomotor, mood, bone, metabolism
• Diet: Mediterranean; phytoestrogens (soy, flax) modest benefit
• Avoid triggers: Alcohol, caffeine, spicy foods, heat, stress

Long-Term Health Considerations

• Bone: Accelerated loss first 5 years; DEXA screening; calcium, Vit D, weight-bearing exercise
• Cardiovascular: Risk accelerates post-menopause; lipid/BP monitoring
• Metabolic: Insulin resistance, central obesity
• Cognitive: Early surgical menopause ↑ dementia risk; MHT timing hypothesis

Shared Decision-Making

Individualize based on symptom severity, health history, preferences, and risk profile. Reassess annually. NAMS-certified providers offer specialized expertise.